RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Intraocular Use of Anti-VEGF Antibody Fragment Improves Vision and Retinal Anatomy in DR
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 8
SP 15
OP 15
DO 10.1177/155989771108009
UL http://mdc.sagepub.com/content/11/8/15.abstract
AB Ranibizumab, an anti-VEGF antibody fragment that is designed for intraocular use in diabetic retinopathy (DR), led to rapid and sustained improvement in both vision and retinal anatomy, reduced progression of DR, and improved patient-reported function in the RISE and RIDE clinical trials.